1-3 of 3
Amanda Leblanc
Close
Sort by
Journal Articles

A Phase I Trial of the Epigenetic Modulators Vorinostat, in Combination with Azacitidine (azaC) in Patients with the Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): A Study of the New York Cancer Consortium

Lewis R. Silverman, MD, Amit Verma, Rosalie Odchimar-Reissig, Amanda LeBlanc, Vesna Najfeld, Janice Gabrilove, Luis Isola, Igor Espinoza-Delgado, MD, James Zwiebel
Journal: Blood
Blood (2008) 112 (11): 3656.
https://doi.org/10.1182/blood.V112.11.3656.3656
Published: 2008
Journal Articles

The Relationship Between Chromosomally Abnormal Hematopoiesis and the JAK2V617F Allele Burden in Patients (pts) with Ph-Negative Chronic Myeloproliferative Disorders (Ph-neg MPD)

Xialoli Wang, MD, Ph.D., Amanda Leblanc, Steven Gruenstein, MD, Mingjiang Xu, Ph.D., Nathaniel Wisch, MD, Ronald Hoffman, MD, Vesna Najfeld, Ph.D
Journal: Blood
Blood (2008) 112 (11): 3106.
https://doi.org/10.1182/blood.V112.11.3106.3106
Published: 2008
Journal Articles

Human Erythroblasts Generated in Vitro Remain Functional with a Normal Karyotype 8 Years after Cryopreservation: Implications for Ex Vivo Generated Erythroid Transfusion Products.

Massimo Sanchez, PhD, Amanda Leblanc, Annalisa Mancini, PhD, Francesca Masiello, PhD, Valentina Tirelli, PhD, Giovanni Migliaccio, PhD, Anna Rita Migliaccio, PhD, Vesna Najfeld, PhD, Carolyn Whitsett, MD
Journal: Blood
Blood (2008) 112 (11): 2303.
https://doi.org/10.1182/blood.V112.11.2303.2303
Published: 2008